HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ACI’s Hockstad Named Top Association Leader

Executive Summary

Association TRENDS’ award recognizes CEO who “currently makes a vital contribution to the leadership of a well-recognized association … and whose stature enables them to serve as an example of all that is best in the association world.”

You may also be interested in...



HBW Market Executive Decisions: Sabinsa, Nutrition21, Council Of Manufacturing Association

Sabinsa founder edits selenium research book; Everwell adds Nutrition21 executives; and ACI’s Hockstad leads NAM Council of Manufacturing Associations.

Tianeptine Rings Latest Unapproved Drug Alarm, Followed By Echo About Lack Of FDA Regulation

Tianeptine isn’t approved as drug in US nor allowed for use as dietary ingredient or food additive. FDA has warned multiple firms selling tianeptine-containing products and federal prosecutors recently announced guilty plea from man who sold the drug to consumers.

Coca-Cola Flexes In Powerade Social Media Posts But Bends Electrolyte Claims To Gatorade Challenge

BBB National Programs’ NARB “troubled” because 50% more electrolytes claim is unclear which Gatorade product the claim references. It finds consumers will understand “leading sports drink” claim references Gatorade and “ambiguous reference” makes “incorrect message” Powerade has 50% more electrolytes than all Gatorade products rather than Gatorade Thirst Quencher alone.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153259

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel